AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
OXALIPLATINE
46 registrations across 4 African markets— 24 active
Markets with OXALIPLATINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| OXALIPLATIN AqVida Solution injectable pour perfusion / 5 mg/ml (100 mg) | 🇹🇳Tunisia | AQVIDA GMBH | expired | Aug 2019 |
| OXALIPLATIN AqVida Solution injectable pour perfusion / 5 mg/ml (50 mg) | 🇹🇳Tunisia | AQVIDA GMBH | expired | Aug 2019 |
| OXALIPLATINE KABI Solution injectable pour perfusion / 5 mg/ml (100 mg) | 🇹🇳Tunisia | FRESENIUS KABI FRANCE | expired | Jul 2019 |
| OXALIPLATINE KABI Solution injectable pour perfusion / 5 mg/ml (50 mg) | 🇹🇳Tunisia | FRESENIUS KABI FRANCE | expired | Jul 2019 |
| OXALIPLATIN ACCORD Solution injectable pour perfusion / 5 mg/ml (50 mg/10ml) | 🇹🇳Tunisia | ACCORD HEALTHCARE LTD | expired | Jan 2017 |
| OXALIPLATIN ACCORD Solution injectable pour perfusion / 5 mg/ml (100 mg/20ml) | 🇹🇳Tunisia | ACCORD HEALTHCARE LTD | expired | Jan 2017 |
| CYTOXALINE Solution injectable pour perfusion / 50 mg/10 ml | 🇹🇳Tunisia | CYTOPHARMA | expired | Jul 2016 |
| CYTOXALINE Solution injectable pour perfusion / 100 mg/20 ml | 🇹🇳Tunisia | CYTOPHARMA | expired | Jul 2016 |
| OXALIPLATINE KABI Solution injectable pour perfusion / 5 mg/ml (50 mg) | 🇹🇳Tunisia | FRESENIUS KABI ONCOLOGY PLC | expired | Feb 2014 |
| OXALIPLATINE KABI Solution injectable pour perfusion / 5 mg/ml (100 mg) | 🇹🇳Tunisia | FRESENIUS KABI ONCOLOGY PLC | expired | Feb 2014 |
| OXALIPLATINE VIATRIS Pdre p.prep.injectable / 5 mg/ml (100 mg) | 🇹🇳Tunisia | VIATRIS SANTE | expired | Jul 2011 |
| OXALIPLATINE VIATRIS Pdre p.prep.injectable / 5 mg/ml (50 mg) | 🇹🇳Tunisia | VIATRIS SANTE | expired | Jul 2011 |
| XALIPLAT 100 Pdre p.prep.injectable / 100 mg | 🇹🇳Tunisia | Laboratorios Richmond S.A.C.I.F | expired | Jul 2010 |
| XALIPLAT 50 Pdre p.prep.injectable / 50 mg | 🇹🇳Tunisia | Laboratorios Richmond S.A.C.I.F | expired | Jul 2010 |
| GOXYRAL Pdre p.prep.injectable / 50 mg | 🇹🇳Tunisia | ERIOCHEM | expired | Jul 2010 |
| GOXYRAL Pdre p.prep.injectable / 100 mg | 🇹🇳Tunisia | ERIOCHEM | expired | Jul 2010 |
| OXALIPLATIN HOSPIRA Solution injectable pour perfusion / 5 mg/ml (50 mg) | 🇹🇳Tunisia | HOSPIRA UK Limited | expired | Jul 2010 |
| OXALIPLATIN HOSPIRA Solution injectable pour perfusion / 5 mg/ml (100mg) | 🇹🇳Tunisia | HOSPIRA UK Limited | expired | Jul 2010 |
| OXALIPLATIN ACTAVIS Pdre p.prep.injectable / 5 mg/ml (50 mg) | 🇹🇳Tunisia | ACTAVIS SRL ROMANIA | expired | Jul 2010 |
| OXALIPLATIN ACTAVIS Pdre p.prep.injectable / 5 mg/ml (100 mg) | 🇹🇳Tunisia | ACTAVIS SRL ROMANIA | expired | Jul 2010 |
| OXALIPLATIN EBEWE Pdre p.prep.injectable / 5 mg/ml (50 mg) | 🇹🇳Tunisia | EBEWE Pharma | expired | Aug 2007 |
| OXALIPLATIN EBEWE Pdre p.prep.injectable / 5 mg/ml (100 mg) | 🇹🇳Tunisia | EBEWE Pharma | expired | Aug 2007 |
| OLIPLAT POUDRE POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| OXAPLATINE MYLAN 5 MG/ML POUDRE POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| ELOXATINE 5 MG/ML SOLUTION A DILUER POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| OLIPLAT POUDRE POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| ELOXATINE 5 MG/ML POUDRE POUR SOLUTION POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| ELOXATIN solution injectable / 5 mg/ml | 🇸🇳Senegal | SANOFI AVENTIS | active | — |
| OXPLATDN 100 MG/50 ML SOLUTION INJECTABLE EN IV FLACON DE 50 ML | 🇨🇮Côte d'Ivoire | DR GOYAL MEDICAL PVT LTD, | active | — |
| ELOXATINE solution injectable / 5 mg/ml | 🇸🇳Senegal | SANOFI AVENTIS | active | — |
| ELOXATIN ampoule injectable / 5 mg/ml | 🇸🇳Senegal | SANOFI AVENTIS | active | — |
| ELOXATINE solution injectable / 5 mg/ml | 🇸🇳Senegal | SANOFI AVENTIS | active | — |
| ELOXATINE 5 MG/ML SOLUTION A DILUER POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| ELOXATINE 5 MG/ML POUDRE POUR SOLUTION POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| ELOXATINE 5 MG/ML POUDRE POUR SOLUTION POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| XYLATIN 100 POUDRE POUR SOLUTION POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| OXALIPLATINE WIN 5 MG/ML POUDRE POUR SOLUTION POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| XYLATIN 50 POUDRE POUR SOLUTION POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| OXALIPLATINE WIN 5 MG/ML POUDRE POUR SOLUTION POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| OXALIPLATINE WIN 5 MG/ML POUDRE POUR SOLUTION POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| ELOXATINE 5 MG/ML POUDRE POUR SOLUTION POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| OXAPLATINE MYLAN 5 MG/ML POUDRE POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| OPLATIN solution injectable / 50 mg / 25 ml | 🇸🇳Senegal | UNITED BIOTECH | active | — |
| OXALISIN 5 MG/ML SOLUTION A DILUER POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| OXALISIN 5 MG/ML SOLUTION A DILUER POUR PERFUSION | 🇲🇦Morocco | — | active | — |
| OXALIPLATINE WIN 5 MG/ML POUDRE POUR SOLUTION POUR PERFUSION | 🇲🇦Morocco | — | active | — |
OXALIPLATINE in Africa — Regulatory Overview
OXALIPLATINE is registered across 4 African markets with 46 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Morocco, Senegal, Côte d'Ivoire. AfricaRegulatory refreshes this data daily from official government sources.
Of the 46 registrations, 24 (52%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.